There is significant variation in both provision for, and access to treatment and support for people with MG across the UK. Meanwhile, whilst the rapidly changing treatment landscape is providing novel treatment opportunities, this may in turn widen those inequalities.
A significant proportion of patients with MG are managed within general neurology clinics. We want to ensure existing general neurologists, registrars, pharmacists, specialist nurses and those new to post have a good understanding of the diagnosis, treatment and management options for patients with MG, and are confident in recognising when and how to seek help from specialist services in the management of complex patients.
The course is fully funded including a travel allowance that will be reimbursed after the MasterClass. There will be a £100 deposit required to secure your in person place, this will be invoiced to you upon confirmation. This deposit will be refunded within 30 days of you completing both modules of the course.
For further details, including; who this course is suitable for, what the course will involve and how the course is taught please visit:
https://neurologyacademy.org/events/course/myasthenia-gravis-masterclass-1
This activity has been funded by sponsorship from UCB Biopharma Srl and argenx BV. The sponsors have had no control over the organisation or educational content this activity.
